Dealing with Bristol-Myers

Dealing with Bristol-Myers

Date Seller/Buyer Compound (status at time of deal) Disease category Upfront/Equity Milestones Initial value
Sep-01 ImClone/ Bristol-Myers Erbitux (submitting rolling BLA) Cancer $1,000

Read the full 269 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE